Breathe Well Live Well
|
Asthma experts form new partnership to halve European asthma deaths
HealthCanal.com Asthma experts from across Europe are uniting as part of a new partnership launched this week to tackle Europe's high asthma prevalence and death rates. The European Asthma Research and Innovation partnership (EARIP) aims to reduce asthma deaths in … |
View full post on asthma – Google News
|
MediciNova Receives a Notice of European Patent Allowance for Treating …
NASDAQ MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis … MediciNova Receives Notice of European Patent Allowance for Treating … |
View full post on asthma – Google News
|
PPD and Global Allergy and Asthma European Network (GA2LEN) Announce …
The Herald | HeraldOnline.com WILMINGTON, N.C., & BERLIN, Germany — Pharmaceutical Product Development, LLC (PPD) and the Global Allergy and Asthma European Network e.V. (GA2LEN) today announced a strategic alliance in which GA2LEN will provide PPD access to the … |
View full post on asthma – Google News
|
GSK, Theravance seek FDA, European approval of COPD/asthma drug
Upstart (blog) Theravance Inc. and partner GlaxoSmithKline are asking regulators to approve a once-a-day… GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and … GSK, Theravance hit up regulators for approval of key asthma/COPD drug GSK seeks approval for drug candidates |
View full post on asthma – Google News
|
SkyePharma's asthma drug gets European marketing nod
Reuters Company sees launching drug across Europe in H2* Stock up 28 pct, top percentage gainer on LSEJuly 3 (Reuters) – Britain's SkyePharma Plc said itsasthma therapy Flutiform got marketing approval from. |
View full post on asthma – Google News
|
SkyePharma asthma drug wins European backing
Reuters UK By Paul Sandle | LONDON (Reuters) – SkyePharma said on Friday its lead product, asthma therapy Flutiform, had been recommended for approval by European regulators, doubling the value of the group's shares. Flutiform was referred to the European … SkyePharma's asthma drug wins European backing |
View full post on asthma – Google News
|
SkyePharma's asthma drug wins European backing
Reuters UK LONDON (Reuters) – British pharmaceutical company SkyePharma said on Friday its asthma therapy Flutiform had been recommended for approval by European regulators, sending its shares soaring. Flutiform was referred to the European Medicines Agency (EMA) … |
View full post on asthma – Google News
|
SkyePharma's Asthma Treatment Faces European Approval Delay; Shares Fall
RTT News PK: News ) plunged on the London Stock Exchange in Tuesday morning trade, after the British drug delivery specialist reported a delay in review of the European Marketing Authorisation Application or MAA for its asthma therapy Flutiform due to lack of … SkyePharma lung drug faces European approval delay |
View full post on asthma – Google News
|
Prevalence of Asthma Symptoms based on the European Community Respiratory …
7thSpace Interactive (press release) FENO is increased in patients with asthma. The relationship between subjective asthma symptoms and airway inflammation is an important issue. We expected that the subjective asthma symptoms in women might be different from those in men. … |
View full post on asthma – Google News
|
Herbal medicine shown to reduce asthma symptoms
European Lung Foundation A traditional herbal medicine has been shown to reduce inflammation in people who suffer from asthma caused by allergens. Half the mice were given the SCRT treatment and half received a dummy treatment. Their lungs were then tested for common asthma … Herbal medicine treatment reduces inflammation in allergen-induced asthma … |
View full post on asthma – Google News